BR112014007474A2 - aumento de rendimento de partícula tipo vírus em plantas - Google Patents
aumento de rendimento de partícula tipo vírus em plantasInfo
- Publication number
- BR112014007474A2 BR112014007474A2 BR112014007474A BR112014007474A BR112014007474A2 BR 112014007474 A2 BR112014007474 A2 BR 112014007474A2 BR 112014007474 A BR112014007474 A BR 112014007474A BR 112014007474 A BR112014007474 A BR 112014007474A BR 112014007474 A2 BR112014007474 A2 BR 112014007474A2
- Authority
- BR
- Brazil
- Prior art keywords
- plant
- nucleic acid
- virus particle
- plants
- particle yield
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 3
- 239000002245 particle Substances 0.000 title abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 6
- 108020004707 nucleic acids Proteins 0.000 abstract 6
- 150000007523 nucleic acids Chemical class 0.000 abstract 6
- 108091006146 Channels Proteins 0.000 abstract 2
- 102000034573 Channels Human genes 0.000 abstract 2
- 239000002773 nucleotide Substances 0.000 abstract 2
- 125000003729 nucleotide group Chemical group 0.000 abstract 2
- 230000001105 regulatory effect Effects 0.000 abstract 2
- 108010067390 Viral Proteins Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16223—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
resumo aumento de rendimento de partícula tipo vírus em plantas um método de produção de uma partícula tipo vírus (vlp) em uma planta é fornecido. o método compreende introduzir um primeiro ácido nucleico de um ácido nucleico e um segundo ácido nucleico na planta, ou em uma porção da planta. o primeiro ácido nucleico compreende uma primeira região reguladora ativa na planta e operativamente ligada a uma sequência de nucleotídeos que codifica uma proteína viral estrutural. o segundo ácido nucleico segundo compreende uma segunda região reguladora ativa na planta e operativamente ligada a uma sequência de nucleotídeos que codifica uma proteína canal, por exemplo, mas sem se limitar, a proteína canal de prótons. a planta ou parte da planta é incubada sob condições que permitem a expressão dos ácidos nucleicos, produzindo assim a vlp.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161541780P | 2011-09-30 | 2011-09-30 | |
PCT/CA2012/050681 WO2013044390A1 (en) | 2011-09-30 | 2012-09-28 | Increasing virus-like particle yield in plants |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014007474A2 true BR112014007474A2 (pt) | 2017-04-04 |
Family
ID=47994080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014007474A BR112014007474A2 (pt) | 2011-09-30 | 2012-09-28 | aumento de rendimento de partícula tipo vírus em plantas |
Country Status (27)
Country | Link |
---|---|
US (1) | US11155581B2 (pt) |
EP (2) | EP2760882B1 (pt) |
JP (1) | JP6248040B2 (pt) |
KR (1) | KR101974017B1 (pt) |
CN (2) | CN103930435A (pt) |
AU (1) | AU2012315421C1 (pt) |
BR (1) | BR112014007474A2 (pt) |
CA (1) | CA2850407C (pt) |
DK (1) | DK2760882T5 (pt) |
ES (1) | ES2951259T3 (pt) |
FI (1) | FI2760882T3 (pt) |
HK (1) | HK1200179A1 (pt) |
HR (1) | HRP20230695T1 (pt) |
HU (1) | HUE062759T2 (pt) |
IL (1) | IL231587B (pt) |
IN (1) | IN2014CN03077A (pt) |
MX (2) | MX358883B (pt) |
MY (1) | MY184072A (pt) |
NZ (1) | NZ622731A (pt) |
PL (1) | PL2760882T3 (pt) |
PT (1) | PT2760882T (pt) |
RU (1) | RU2682752C2 (pt) |
SG (2) | SG10201708052XA (pt) |
SI (1) | SI2760882T1 (pt) |
TW (1) | TWI700368B (pt) |
WO (1) | WO2013044390A1 (pt) |
ZA (1) | ZA201403059B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2760882T (pt) | 2011-09-30 | 2023-08-07 | Medicago Inc | Aumento do rendimento de partícula semelhante a vírus em plantas |
US11390878B2 (en) | 2011-09-30 | 2022-07-19 | Medicago Inc. | Increasing protein yield in plants |
CN112592389A (zh) | 2013-03-28 | 2021-04-02 | 莫迪卡戈公司 | 植物中流感样病毒颗粒的产生 |
CN105980561B (zh) * | 2014-01-10 | 2020-06-02 | 莫迪卡戈公司 | Cpmv增强子元件 |
US10563213B2 (en) | 2014-03-27 | 2020-02-18 | Medicago Inc. | Modified CPMV enhancer elements |
CN112400021A (zh) * | 2018-03-14 | 2021-02-23 | 麦迪卡格公司 | 植物表达增强子 |
EP3814507A4 (en) * | 2018-06-27 | 2022-07-06 | Medicago Inc. | INFLUENZA VIRUS HEMAGGLUTININ MUTANTS |
EP3938511A4 (en) * | 2019-03-14 | 2023-02-08 | Mitsubishi Tanabe Pharma Corporation | ENDOGENOUS PLANT EXPRESSION ACTIVATOR |
WO2021236908A2 (en) * | 2020-05-20 | 2021-11-25 | Biomarin Pharmaceutical Inc. | Use of regulatory proteins for the production of adeno-associated virus |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5428147A (en) | 1983-04-15 | 1995-06-27 | Mycogen Plant Science, Inc. | Octopine T-DNA promoters |
US5036006A (en) | 1984-11-13 | 1991-07-30 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
US5100792A (en) | 1984-11-13 | 1992-03-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues |
US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
US4962028A (en) | 1986-07-09 | 1990-10-09 | Dna Plant Technology Corporation | Plant promotors |
US5232833A (en) | 1988-09-14 | 1993-08-03 | Stressgen Biotechnologies Corporation | Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants |
US5805417A (en) | 1995-10-13 | 1998-09-08 | Hitachi, Ltd. | Heat dissipation structure in a portable computer including a heat dissipation block extending from a heat dissipation plate through a first circuit board to a CPU on a second circuit board |
AU6512299A (en) | 1998-10-07 | 2000-04-26 | Boyce Institute For Plant Research At Cornell University | Gemini virus vectors for gene expression in plants |
US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
RU2164148C1 (ru) * | 2000-08-09 | 2001-03-20 | Петров Рэм Викторович | Вакцина против вируса гриппа и способ ее получения |
BRPI0410340A (pt) * | 2003-05-05 | 2006-05-30 | Dow Agrosciences Llc | vetores e células para preparar composições imunoprotetoras derivadas de plantas transgênicas |
EP1635772A4 (en) | 2003-05-05 | 2008-02-13 | Dow Agrosciences Llc | STERILE IMMUNOPROPHYLACTIC AND THERAPEUTIC COMPOSITIONS DERIVED FROM TRANSGENIC VEGETABLE CELLS AND METHODS OF PRODUCTION THEREOF |
ES2662118T3 (es) * | 2005-04-29 | 2018-04-05 | University Of Cape Town | Expresión de proteínas virales en las plantas |
US7871626B2 (en) * | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
SG2014012868A (en) | 2005-10-18 | 2014-09-26 | Novavax Inc | Functional influenza virus like particles (vlps) |
WO2007051036A2 (en) * | 2005-10-26 | 2007-05-03 | Protelix, Inc. | Influenza combinatorial antigen vaccine |
WO2007100584A2 (en) | 2006-02-16 | 2007-09-07 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Antiviral agents and vaccines against influenza |
CA2638760A1 (en) | 2006-03-07 | 2007-09-13 | Vaxinnate Corporation | Compositions that include hemagglutinin, methods of making and methods of use thereof |
WO2008054535A2 (en) | 2006-05-11 | 2008-05-08 | Novavax, Inc. | Novel influenza m2 vaccines |
WO2007135480A1 (en) | 2006-05-22 | 2007-11-29 | Plant Bioscience Limited | Bipartite system, method and composition for the constitutive and inducible expression of high levels of foreign proteins in plants |
CA2654178A1 (en) * | 2006-06-16 | 2007-12-27 | Dow Agrosciences Llc | Novel dna sequences, vectors and proteins of avian influenza hemagglutinin |
US8697088B2 (en) | 2007-05-25 | 2014-04-15 | Novavax, Inc. | VLPs derived from cells that do not express a viral matrix or core protein |
RU2499053C2 (ru) | 2007-06-15 | 2013-11-20 | Медикаго Инк. | Способ синтеза белка с модифицированным профилем n-гликозилирования в растениях |
CA2615372A1 (en) * | 2007-07-13 | 2009-01-13 | Marc-Andre D'aoust | Influenza virus-like particles (vlps) comprising hemagglutinin |
EP2610345B1 (en) | 2007-11-27 | 2015-08-19 | Medicago Inc. | Recombinant influenza virus-like particles (VLPS) produced in transgenic plants expressing hemagglutinin |
GB0800272D0 (en) | 2008-01-08 | 2008-02-13 | Plant Bioscience Ltd | Protein expression systems |
KR101956910B1 (ko) | 2008-01-21 | 2019-03-12 | 메디카고 인코포레이티드 | 헤마글루티닌을 발현하는 트랜스제닉 식물에서 생산된 재조합 인플루엔자 바이러스-유사 입자(VLPs) |
EP2294202B1 (en) | 2008-07-08 | 2015-05-20 | Medicago Inc. | Soluble recombinant influenza antigens |
PT2318530T (pt) * | 2008-07-18 | 2016-09-30 | Medicago Inc | Novo epítopo de imunização contra o vírus da gripe |
CA2736796A1 (en) | 2008-08-27 | 2010-03-04 | Arizona Board Of Regents For And On Behalf Of Arizona State University | A dna replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants |
CA2787099A1 (en) * | 2009-03-30 | 2010-10-14 | Anice C. Lowen | Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof |
US10272148B2 (en) | 2009-06-24 | 2019-04-30 | Medicago Inc. | Chimeric influenza virus-like particles comprising hemagglutinin |
FR2947875B1 (fr) | 2009-07-10 | 2011-07-08 | Raymond A & Cie | Dispositif de fixation a elements de fixation multiples dont l'un est flottant |
WO2011011390A1 (en) * | 2009-07-20 | 2011-01-27 | Novavax, Inc. | Purified recombinant influenza virus ha proteins |
PT3354657T (pt) | 2009-09-22 | 2022-05-06 | Medicago Inc | Método de preparação de proteínas derivadas de plantas |
EP2536428B1 (en) | 2010-02-18 | 2018-12-05 | Technovax, Inc. | Universal virus-like particle (vlp) influenza vaccines |
US10226527B2 (en) | 2010-10-04 | 2019-03-12 | Massachusetts Institute Of Technology | Hemagglutinin polypeptides, and reagents and methods relating thereto |
TWI526539B (zh) | 2010-12-22 | 2016-03-21 | 苜蓿股份有限公司 | 植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp |
PL220281B1 (pl) | 2011-09-23 | 2015-09-30 | Inst Biochemii I Biofizyki Polskiej Akademii Nauk | Szczepionka DNA, sposób indukowania odpowiedzi immunologicznej, przeciwciała specyficznie rozpoznające białko hemaglutyniny H5 wirusa grypy i zastosowanie szczepionki DNA |
PT2760882T (pt) | 2011-09-30 | 2023-08-07 | Medicago Inc | Aumento do rendimento de partícula semelhante a vírus em plantas |
US11390878B2 (en) * | 2011-09-30 | 2022-07-19 | Medicago Inc. | Increasing protein yield in plants |
US9555094B2 (en) | 2012-07-23 | 2017-01-31 | The Institute Of Biological Resources | Isolated nucleic acid for the production of a vaccine against virus |
CN112592389A (zh) | 2013-03-28 | 2021-04-02 | 莫迪卡戈公司 | 植物中流感样病毒颗粒的产生 |
-
2012
- 2012-09-28 PT PT128365459T patent/PT2760882T/pt unknown
- 2012-09-28 US US14/347,804 patent/US11155581B2/en active Active
- 2012-09-28 SG SG10201708052XA patent/SG10201708052XA/en unknown
- 2012-09-28 CN CN201280047819.2A patent/CN103930435A/zh active Pending
- 2012-09-28 NZ NZ622731A patent/NZ622731A/en unknown
- 2012-09-28 CA CA2850407A patent/CA2850407C/en active Active
- 2012-09-28 HU HUE12836545A patent/HUE062759T2/hu unknown
- 2012-09-28 PL PL12836545.9T patent/PL2760882T3/pl unknown
- 2012-09-28 HR HRP20230695TT patent/HRP20230695T1/hr unknown
- 2012-09-28 CN CN202310130025.2A patent/CN116218900A/zh active Pending
- 2012-09-28 SG SG11201400712VA patent/SG11201400712VA/en unknown
- 2012-09-28 TW TW101135891A patent/TWI700368B/zh active
- 2012-09-28 WO PCT/CA2012/050681 patent/WO2013044390A1/en active Application Filing
- 2012-09-28 AU AU2012315421A patent/AU2012315421C1/en active Active
- 2012-09-28 KR KR1020147011886A patent/KR101974017B1/ko active IP Right Grant
- 2012-09-28 EP EP12836545.9A patent/EP2760882B1/en active Active
- 2012-09-28 EP EP19205918.6A patent/EP3626733B1/en active Active
- 2012-09-28 SI SI201232036T patent/SI2760882T1/sl unknown
- 2012-09-28 ES ES12836545T patent/ES2951259T3/es active Active
- 2012-09-28 JP JP2014532198A patent/JP6248040B2/ja active Active
- 2012-09-28 RU RU2014116371A patent/RU2682752C2/ru active
- 2012-09-28 MX MX2014003776A patent/MX358883B/es active IP Right Grant
- 2012-09-28 FI FIEP12836545.9T patent/FI2760882T3/fi active
- 2012-09-28 DK DK12836545.9T patent/DK2760882T5/da active
- 2012-09-28 BR BR112014007474A patent/BR112014007474A2/pt not_active Application Discontinuation
- 2012-09-28 MY MYPI2014700716A patent/MY184072A/en unknown
- 2012-09-28 IN IN3077CHN2014 patent/IN2014CN03077A/en unknown
-
2014
- 2014-03-19 IL IL231587A patent/IL231587B/en active IP Right Grant
- 2014-03-28 MX MX2018006627A patent/MX2018006627A/es unknown
- 2014-04-29 ZA ZA2014/03059A patent/ZA201403059B/en unknown
-
2015
- 2015-01-21 HK HK15100674.6A patent/HK1200179A1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014007474A2 (pt) | aumento de rendimento de partícula tipo vírus em plantas | |
BRPI1015053A2 (pt) | partículas similares a vírus da influenza quiméricas compreendendo hemaglutinina | |
BR112014027736A2 (pt) | produção de partícula semelhante a rotavírus em plantas | |
MX2010003202A (es) | Metodo para producir virus de la gripe. | |
TN2009000557A1 (en) | Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant | |
WO2013039861A3 (en) | Engineered nucleic acids and methods of use thereof | |
AR089440A1 (es) | Procesos que emplean particulas similares a virus (psv) con capsides resistentes a hidrolasas | |
BR112018013168A2 (pt) | vírus mutantes, método de preparação e uso dos mesmos | |
EA201001198A1 (ru) | Рекомбинантные вирусоподобные частицы (вч), схожие с вирусом гриппа, производящиеся в трансгенных растениях, экспрессирующих гемагглютинин | |
MX350421B (es) | Producción de partículas tipo virus de la rabia en plantas. | |
MX2021006342A (es) | Mutantes de virus de influenza y usos para los mismos. | |
WO2012083445A8 (en) | Virus like particle production in plants | |
AR078432A1 (es) | Metodo para preparar particulas similares a virus (psv) derivadas de plantas | |
BR112013011194A2 (pt) | partículas de glicoproteína semelhantes a vírus (vlps) da raiva. | |
MY161965A (en) | New influenza virus immunizing epitope | |
MX2014000753A (es) | Procedimiento para producir antigeno viral y vacunas. | |
AR087167A1 (es) | Genes de resistencia al tizon tardio | |
BR112015006798A2 (pt) | vírus da vacínia ankara modificado, genoma, célula, métodos para cultivar um vírus mva, para produzir um vírus mva e para produzir um vírus mva recombinante, composição farmacêutica, vacina, vírus mva ou genoma, e, molécula de ácido nucleico | |
BR112015014755A2 (pt) | processo para preparar bio-sinteticamente n-propanol, ácido propiônico, ou uma combinação dos mesmos, processo para modificar uma propionibactéria para uso na biossíntese de n-propanol ou ácido propiônico e propionibactéria modificada para uso na biossíntese | |
BR112020026620A8 (pt) | Mutantes de hemaglutinina do vírus influenza | |
FR2962739B1 (fr) | Souches virales modifiees et procede pour ameliorer la production de semences vaccinales de virus influenza | |
BR112015004714A2 (pt) | produção de partícula semelhante a picornavírus em plantas | |
BR112022006863A2 (pt) | Sistemas e métodos de isolamento de gálio-68 | |
BR112015021772A2 (pt) | método para a preparação de células embrionárias aviárias, método melhorado para a preparação de células embrionárias aviárias a partir de um embrião, cultura ou composição de células embrionárias aviárias, método para a produção ou amplificação de um vírus, e, composição de vacina | |
BR112015024790A2 (pt) | produção de partícula semelhante a vírus influenza em plantas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Ipc: C07K 14/005 (2006.01), A61K 39/145 (2006.01), C07K |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] |